\-\ Texto\\:\\ \ \(0\)\
\-\ bp\\:\\ 109\\/75\\,\\ \\ \\ \\ \\ hr\\:\\ 111\\,\\ \\ \\ \\ \\ rr\\:\\ 14\\,\\ \\ \\ \\ \\ t\\:\\ 97\\.8\\ \\Â\\°f\\,\\ \\ \\ \\ \\ ht\\:\\ 72\\ in\\,\\ \\ \\ \\ \\ wt\\:\\ 176\\ lbs\ \(0\)\
\-\ general\\ appearance\\:\ \(0\)\
\-\ \\Â\\°\\ normal\\.\\ \\ \\Â\\°\\ well\\ developed\\.\\ \\ \\Â\\°\\ well\\ nourished\\.\\ \\ \\Â\\°\\ in\\ no\\ acute\\ distress\\.\ \(0\)\
\-\ head\\:\ \(5\)\
\-\ injuries\\:\\ \\Â\\°\\ no\\ evidence\\ of\\ a\\ head\\ injury\\.\ \(0\)\
\-\ appearance\\:\\ \\Â\\°\\ head\\ normocephalic\\.\ \(0\)\
\-\ eyes\\:\ \(0\)\
\-\ pupils\\:\\ \\Â\\°\\ perrl\\.\\ \\ \\Â\\°\\ size\\ of\\ the\\ pupil\\ was\\ normal\\.\\ \\ \\Â\\°\\ pupil\\ accommodation\\ was\\ not\\ impaired\\.\ \(0\)\
\-\ external\\:\\ \\Â\\°\\ eyelids\\ showed\\ no\\ abnormalities\\.\\ \\ \\Â\\°\\ conjunctiva\\ exhibited\\ no\\ abnormalities\\.\ \(0\)\
\-\ sclera\\:\\ \\Â\\°\\ normal\\.\ \(0\)\
\-\ musculoskeletal\\ system\\:\\ nml\ \(0\)\
\-\ functional\\ exam\\:\ \(0\)\
\-\ general\\/bilateral\\:\\ \\Â\\°\\ mobility\\ was\\ not\\ limited\\.\ \(0\)\
\-\ neurological\\:\ \(0\)\
\-\ \\Â\\°\\ oriented\\ to\\ time\\,\\ place\\,\\ and\\ person\\.\ \(0\)\
\-\ cranial\\ nerves\\:\\ \\Â\\°\\ normal\\.\ \(0\)\
\-\ balance\\:\\ \\Â\\°\\ normal\\.\\ \\ \\Â\\°\\ romberg\\'s\\ sign\\ was\\ absent\\.\ \(0\)\
\-\ gait\\ and\\ stance\\:\\ \\Â\\°\\ normal\\.\ \(0\)\
\-\ trans\\-sphenoidal\\ resection\\ of\\ pituitary\\ adenoma\\.\\ 6\\ month\\ post\\-op\\ mri\\ showed\\ empty\\ sella\\ with\\ trace\\ residual\\ pituitary\\ parenchyma\\ along\\ the\\ lateral\\ margins\\.\\ 6\\ month\\ postop\\ visual\\ field\\ testing\\ showed\\ complete\\ return\\ of\\ visual\\ fields\\ and\\ left\\ eye\\,\\ but\\ residual\\ temporal\\ hemianopsia\\ of\\ the\\ right\\ eye\\ with\\ minimal\\ return\\ of\\ central\\ vision\\ on\\ the\\ right\\.\ \(0\)\
\-\ as\\ clinically\\ suspected\\,\\ there\\ is\\ a\\ large\\ suprasellar\\ mass\\ which\\ \\	\ \(0\)\
\-\ \\ \\ \\ \\ measures\\ approximately\\ 39\\ mm\\ cc\\ x\\ 24\\ mm\\ tr\\ x\\ 23\\ mm\\ ap\\.\\ 50\\%\\ of\\ the\\ mass\\ is\\ \\	\ \(0\)\
\-\ \\ \\ \\ \\ suprasellar\\ and\\ 50\\%\\ is\\ within\\ the\\ sella\\.\\ as\\ such\\,\\ the\\ mass\\ shape\\ is\\ somewhat\\ \\	\ \(0\)\
\-\ \\ \\ \\ \\ dumbbell\\ in\\ morphology\\.\\ the\\ sella\\ appears\\ expanded\\.\\ the\\ mass\\ signal\\ intensity\\ is\\	\ \(0\)\
\-\ \\ \\ \\ \\ mixed\\ with\\ multiple\\ globular\\ sites\\ of\\ t2\\ and\\ t1\\ hyperintensity\\ measuring\\ on\\ the\\ \\	\ \(0\)\
\-\ \\ \\ \\ \\ order\\ of\\ 8\\ mm\\ interposed\\ with\\ solid\\ appearing\\,\\ isointense\\ to\\ brain\\ parenchyma\\ \\	\ \(1\)\
\-\ \\ \\ \\ \\ tissue\\ mostly\\ compatible\\ with\\ areas\\ of\\ cystic\\ degeneration\\ with\\ or\\ without\\ some\\ \\	\ \(1\)\
\-\ \\ \\ \\ \\ degree\\ of\\ hemorrhage\\.\\ there\\ is\\ superior\\ mass\\ effect\\ upon\\ the\\ optic\\ chiasm\\.\\ \\	\\	\ \(0\)\
\-\ \\ \\ \\ \\ in\\ other\\ regards\\,\\ the\\ brainstem\\,\\ cerebellum\\,\\ and\\ cerebral\\ hemispheres\\ are\\ \\	\ \(0\)\
\-\ \\ \\ \\ \\ otherwise\\ normal\\ in\\ morphology\\ without\\ evidence\\ of\\ other\\ abnormal\\ enhancement\\,\\ \\	\ \(1\)\
\-\ \\ \\ \\ \\ other\\ mass\\ lesion\\,\\ hemorrhage\\,\\ midline\\ shift\\,\\ or\\ ischemia\\.\\ gray\\-white\\ matter\\ \\	\ \(0\)\
\-\ \\ \\ \\ \\ differentiation\\ is\\ appropriate\\.\\ specifically\\,\\ no\\ abnormal\\ t2\\ or\\ flair\\ signal\\ \\	\ \(0\)\
\-\ \\ \\ \\ \\ alteration\\ is\\ present\\ and\\ no\\ restricted\\ diffusion\\ is\\ identified\\.\\ \\	\\	\ \(1\)\
\-\ \\ \\ \\ \\ the\\ ventricles\\,\\ basal\\ cisterns\\,\\ and\\ sulci\\ are\\ appropriate\\ volume\\ for\\ the\\ \\	\ \(0\)\
\-\ \\ \\ \\ \\ patient\\'s\\ age\\.\\ no\\ abnormal\\ extra\\-axial\\ fluid\\ or\\ mass\\ lesion\\ is\\ present\\.\\ \\	\\	\ \(0\)\
\-\ \\ \\ \\ \\ the\\ orbital\\ contents\\ are\\ unremarkable\\.\\ no\\ discrete\\ middle\\ ear\\ abnormality\\ is\\ \\	\ \(0\)\
\-\ \\ \\ \\ \\ appreciated\\.\\ \\	\\	\ \(1\)\
\-\ \\ \\ \\ \\ the\\ visualized\\ paranasal\\ sinuses\\ and\\ mastoid\\ air\\ cells\\ are\\ clear\\.\\ the\\ remainder\\ \\	\ \(0\)\
\-\ \\ \\ \\ \\ of\\ the\\ visualized\\ soft\\ tissues\\ and\\ osseous\\ structures\\ are\\ normal\\.\\ \\	\\	\ \(1\)\
\-\ \\ \\ \\ \\ impression\\:\\ findings\\ essentially\\ diagnostic\\ large\\ 4\\ cm\\ pituitary\\ macroadenoma\\.\ \(0\)\
\-\ pituitary\\ macroadenoma\ \(8\)\
\-\ pituitary\\ macroadenoma\\,\\ pituitary\\ carcinoma\\,\\ meningioma\\,\\ craniopharyngioma\\,\\ lymphocytic\\ hypophysitis\ \(0\)\
\-\ 23\\ yo\\ man\\ presented\\ to\\ the\\ clinic\\ for\\ required\\ annual\\ physical\\.\\ \\ patient\\ had\\ obvious\\ visual\\ field\\ defects\\ in\\ the\\ lateral\\ fields\\.\\ \\ visual\\ field\\ mapping\\ was\\ then\\ done\\ with\\ optometry\\ the\\ same\\ day\\ which\\ showed\\ bitemporal\\ hemianopsia\\.\ \(0\)\
\-\ pituitary\\ macroadenomas\\ are\\ benign\\ epithelial\\ neoplasms\\ composed\\ of\\ adenohypophysial\\ cells\\ and\\ account\\ for\\ 10\\-15\\%\\ of\\ all\\ intracranial\\ tumors\\.\\ tumors\\ exceeding\\ 10\\ mm\\ are\\ defined\\ as\\ macroadenomas\\,\\ and\\ those\\ smaller\\ than\\ 10\\ mm\\ are\\ termed\\ microadenomas\\.\\ most\\ pituitary\\ adenomas\\ are\\ microadenomas\\.\\ \\ morbidity\\ \\ varies\\ from\\ incidentally\\ discovered\\ nonfunctioning\\ tumors\\ to\\ disabling\\ macroadenomas\\.\\ morbidity\\ results\\ from\\ mass\\ effect\\,\\ hormonal\\ imbalance\\,\\ and\\ patient\\ comorbidities\\.\\ women\\ of\\ childbearing\\ age\\ are\\ diagnosed\\ more\\ frequently\\ with\\ pituitary\\ adenomas\\ as\\ compared\\ to\\ men\\,\\ possibly\\ due\\ to\\ presenting\\ complaint\\ of\\ amenorrhea\\.\\ incidence\\ increases\\ with\\ age\\,\\ peaking\\ between\\ the\\ third\\ and\\ sixth\\ decades\\.\\ patients\\ with\\ pituitary\\ macroadenomas\\ may\\ be\\ asymptomatic\\ or\\ may\\ present\\ with\\ complaints\\ due\\ to\\ hormonal\\ imbalance\\ or\\ mass\\ effects\\,\\ such\\ as\\ visual\\ deficits\\,\\ headache\\,\\ elevated\\ intracranial\\ pressure\\,\\ or\\ intracranial\\ hemorrhage\\ \ \(0\)\
\-\ mulinda\\,\\ jr\\.\\ pituitary\\ macroadenomas\\.\\ www\\.emedicine\\.com\\/med\\/topic1379\\.htm\\.\\ accessed\\ on\\ june\\ 12\\,\\ 2017\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\Â\\°\\:\\ 0\\.2063957064418588\ \(0\)\
\-\ pituitary\\:\\ 0\\.07000313259873056\ \(0\)\
\-\ macroadenomas\\:\\ 0\\.06034451146661629\ \(0\)\
\-\ \\:\\:\\ 0\\.036948062335504656\ \(0\)\
\-\ visual\\:\\ 0\\.028780653799087622\ \(0\)\
\-\ mm\\:\\ 0\\.02801362695508177\ \(0\)\
\-\ macroadenoma\\:\\ 0\\.025129857029503204\ \(0\)\
\-\ microadenomas\\:\\ 0\\.022077931836096902\ \(0\)\
\-\ sella\\:\\ 0\\.021948134290590806\ \(0\)\
\-\ imbalance\\:\\ 0\\.02141480092580207\ \(0\)\
\-\ field\\:\\ 0\\.01954547529772593\ \(0\)\
\-\ pupil\\:\\ 0\\.019071688413575417\ \(0\)\
\-\ hormonal\\:\\ 0\\.018149979859923587\ \(0\)\
\-\ are\\:\\ 0\\.01730867566908769\ \(0\)\
\-\ hemianopsia\\:\\ 0\\.0170118156630258\ \(0\)\
\-\ adenomas\\:\\ 0\\.016879715328491376\ \(0\)\
\-\ showed\\:\\ 0\\.016652619720200275\ \(0\)\
\-\ intracranial\\:\\ 0\\.016098863611692583\ \(0\)\
\-\ normal\\:\\ 0\\.01592407078275306\ \(0\)\
\-\ mass\\:\\ 0\\.015893237834365647\ \(0\)\
\-\ morbidity\\:\\ 0\\.015466866304078078\ \(0\)\
\-\ morphology\\:\\ 0\\.015161801953230877\ \(0\)\
\-\ \\,\\:\\ 0\\.014480776164371984\ \(0\)\
\-\ tumors\\:\\ 0\\.014307799514132991\ \(0\)\
\-\ fields\\:\\ 0\\.013838440833898442\ \(0\)\
\-\ suprasellar\\:\\ 0\\.013838440833898442\ \(0\)\
\-\ 109\\/75\\:\\ 0\\.013098838668598066\ \(0\)\
\-\ adenohypophysial\\:\\ 0\\.013098838668598066\ \(0\)\
\-\ mulinda\\:\\ 0\\.013098838668598066\ \(0\)\
\-\ www\\.emedicine\\.com\\/med\\/topic1379\\.htm\\:\\ 0\\.013098838668598066\ \(0\)\
\-\ return\\:\\ 0\\.012858490502925285\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.012678706913117543\ \(0\)\
\-\ residual\\:\\ 0\\.012602696717572408\ \(0\)\
\-\ 23\\:\\ 0\\.012071109161545716\ \(0\)\
\-\ 176\\:\\ 0\\.012068902293323257\ \(0\)\
\-\ general\\/bilateral\\:\\ 0\\.012068902293323257\ \(0\)\
\-\ peaking\\:\\ 0\\.012068902293323257\ \(0\)\
\-\ appropriate\\:\\ 0\\.011970361608274747\ \(0\)\
\-\ age\\:\\ 0\\.011593953902872094\ \(0\)\
\-\ 97\\.8\\:\\ 0\\.011466428135658823\ \(0\)\
\-\ trans\\-sphenoidal\\:\\ 0\\.011466428135658823\ \(0\)\
\-\ dumbbell\\:\\ 0\\.011466428135658823\ \(0\)\
\-\ hypophysitis\\:\\ 0\\.011466428135658823\ \(0\)\
\-\ optometry\\:\\ 0\\.011466428135658823\ \(0\)\
\-\ stance\\:\\ 0\\.011038965918048451\ \(0\)\
\-\ postop\\:\\ 0\\.011038965918048451\ \(0\)\
\-\ amenorrhea\\:\\ 0\\.011038965918048451\ \(0\)\
\-\ abnormal\\:\\ 0\\.010863709837956514\ \(0\)\
\-\ parenchyma\\:\\ 0\\.0108153601527271\ \(0\)\
\-\ head\\:\\ 0\\.010803571963925241\ \(0\)\
\-\ eye\\:\\ 0\\.010652035087999737\ \(0\)\
\-\ nonfunctioning\\:\\ 0\\.010436491760384015\ \(0\)\
\-\ or\\:\\ 0\\.01041702710660617\ \(0\)\
\-\ visualized\\:\\ 0\\.010279144574426404\ \(0\)\
\-\ no\\:\\ 0\\.01022816226690998\ \(0\)\
\-\ \\Â\\°f\\:\\ 0\\.010207441716064167\ \(0\)\
\-\ tr\\:\\ 0\\.010207441716064167\ \(0\)\
\-\ exceeding\\:\\ 0\\.010207441716064167\ \(0\)\
\-\ childbearing\\:\\ 0\\.010207441716064167\ \(0\)\
\-\ cells\\:\\ 0\\.010182605331797911\ \(0\)\
\-\ accommodation\\:\\ 0\\.010009029542773643\ \(0\)\
\-\ eyelids\\:\\ 0\\.010009029542773643\ \(0\)\
\-\ globular\\:\\ 0\\.010009029542773643\ \(0\)\
\-\ disabling\\:\\ 0\\.010009029542773643\ \(0\)\
\-\ comorbidities\\:\\ 0\\.009834017602719581\ \(0\)\
\-\ interposed\\:\\ 0\\.00967746408762623\ \(0\)\
\-\ mapping\\:\\ 0\\.00967746408762623\ \(0\)\
\-\ 50\\:\\ 0\\.009661212530887978\ \(0\)\
\-\ as\\:\\ 0\\.009603101826850875\ \(0\)\
\-\ conjunctiva\\:\\ 0\\.009535844206787708\ \(0\)\
\-\ romberg\\:\\ 0\\.009535844206787708\ \(0\)\
\-\ regards\\:\\ 0\\.009535844206787708\ \(0\)\
\-\ 111\\:\\ 0\\.009406555385109209\ \(0\)\
\-\ gray\\-white\\:\\ 0\\.009406555385109209\ \(0\)\
\-\ abnormalities\\:\\ 0\\.009327680896577166\ \(0\)\
\-\ is\\:\\ 0\\.009190488205396705\ \(0\)\
\-\ exhibited\\:\\ 0\\.00917750534078936\ \(0\)\
\-\ expanded\\:\\ 0\\.009074989929961794\ \(0\)\
\-\ 2017\\:\\ 0\\.009074989929961794\ \(0\)\
\-\ effect\\:\\ 0\\.008991257810012615\ \(0\)\
\-\ perrl\\:\\ 0\\.008979093167498836\ \(0\)\
\-\ bitemporal\\:\\ 0\\.008979093167498836\ \(0\)\
\-\ \\%\\:\\ 0\\.00888553209515308\ \(0\)\
\-\ other\\:\\ 0\\.008779963812938106\ \(0\)\
\-\ sclera\\:\\ 0\\.008723743602971854\ \(0\)\
\-\ nml\\:\\ 0\\.008723743602971854\ \(0\)\
\-\ ht\\:\\ 0\\.008647527712351421\ \(0\)\
\-\ paranasal\\:\\ 0\\.008647527712351421\ \(0\)\
\-\ 10\\-15\\:\\ 0\\.008647527712351421\ \(0\)\
\-\ jr\\:\\ 0\\.008647527712351421\ \(0\)\
\-\ present\\:\\ 0\\.008603307967006006\ \(0\)\
\-\ alteration\\:\\ 0\\.008575031183124925\ \(0\)\
\-\ 10\\:\\ 0\\.008560547483943269\ \(0\)\
\-\ termed\\:\\ 0\\.0085059078315129\ \(0\)\
\-\ x\\:\\ 0\\.008377611694940496\ \(0\)\
\-\ trace\\:\\ 0\\.0083766190098344\ \(0\)\
\-\ sixth\\:\\ 0\\.0083766190098344\ \(0\)\
\-\ varies\\:\\ 0\\.008315962257204008\ \(0\)\
\-\ june\\:\\ 0\\.008315962257204008\ \(0\)\
\-\ empty\\:\\ 0\\.008257684823098091\ \(0\)\
\-\ impaired\\:\\ 0\\.008201607069780341\ \(0\)\
\-\ person\\:\\ 0\\.008201607069780341\ \(0\)\
\-\ wt\\:\\ 0\\.008147568965514553\ \(0\)\
\-\ decades\\:\\ 0\\.008147568965514553\ \(0\)\
\-\ accessed\\:\\ 0\\.008147568965514553\ \(0\)\
\-\ lymphocytic\\:\\ 0\\.008095427331322472\ \(0\)\
\-\ mobility\\:\\ 0\\.008045053554686987\ \(0\)\
\-\ such\\:\\ 0\\.007938581842023335\ \(0\)\
\-\ cisterns\\:\\ 0\\.007816003510367138\ \(0\)\
\-\ normocephalic\\:\\ 0\\.007774144852169968\ \(0\)\
\-\ balance\\:\\ 0\\.007774144852169968\ \(0\)\
\-\ composed\\:\\ 0\\.007774144852169968\ \(0\)\
\-\ epithelial\\:\\ 0\\.007733433152039039\ \(0\)\
\-\ nourished\\:\\ 0\\.007655210665433658\ \(0\)\
\-\ month\\:\\ 0\\.007618468174741781\ \(0\)\
\-\ 6\\:\\ 0\\.007584309543461736\ \(0\)\
\-\ chiasm\\:\\ 0\\.007545094807850118\ \(0\)\
\-\ post\\-op\\:\\ 0\\.007442579397022553\ \(0\)\
\-\ increases\\:\\ 0\\.007442579397022553\ \(0\)\
\-\ mostly\\:\\ 0\\.007409921288970881\ \(0\)\
\-\ effects\\:\\ 0\\.007409921288970881\ \(0\)\
\-\ was\\:\\ 0\\.0073423292883632\ \(0\)\
\-\ lbs\\:\\ 0\\.007316044763530269\ \(0\)\
\-\ discrete\\:\\ 0\\.007316044763530269\ \(0\)\
\-\ mastoid\\:\\ 0\\.007316044763530269\ \(0\)\
\-\ appearance\\:\\ 0\\.007262723853594773\ \(0\)\
\-\ sulci\\:\\ 0\\.007256601472870983\ \(0\)\
\-\ 72\\:\\ 0\\.007199445037762818\ \(0\)\
\-\ t2\\:\\ 0\\.007187485196880689\ \(0\)\
\-\ contents\\:\\ 0\\.007171670694505533\ \(0\)\
\-\ account\\:\\ 0\\.007171670694505533\ \(0\)\
\-\ men\\:\\ 0\\.007171670694505533\ \(0\)\
\-\ brainstem\\:\\ 0\\.007117632590239745\ \(0\)\
\-\ specifically\\:\\ 0\\.007117632590239745\ \(0\)\
\-\ essentially\\:\\ 0\\.007117632590239745\ \(0\)\
\-\ compatible\\:\\ 0\\.007015117179412181\ \(0\)\
\-\ functional\\:\\ 0\\.006990556552441585\ \(0\)\
\-\ hyperintensity\\:\\ 0\\.006990556552441585\ \(0\)\
\-\ pupils\\:\\ 0\\.006942620650185684\ \(0\)\
\-\ sites\\:\\ 0\\.006919220416949221\ \(0\)\
\-\ eyes\\:\\ 0\\.006829139255260611\ \(0\)\
\-\ cc\\:\\ 0\\.006807447131306446\ \(0\)\
\-\ impression\\:\\ 0\\.006786067135092331\ \(0\)\
\-\ due\\:\\ 0\\.006776455135075303\ \(0\)\
\-\ hemispheres\\:\\ 0\\.006764990411478726\ \(0\)\
\-\ differentiation\\:\\ 0\\.006764990411478726\ \(0\)\
\-\ extra\\-axial\\:\\ 0\\.006764990411478726\ \(0\)\
\-\ craniopharyngioma\\:\\ 0\\.006723713198838198\ \(0\)\
\-\ signal\\:\\ 0\\.006695614651627871\ \(0\)\
\-\ evidence\\:\\ 0\\.006658076027836189\ \(0\)\
\-\ musculoskeletal\\:\\ 0\\.006644447254253809\ \(0\)\
\-\ shape\\:\\ 0\\.0066063455742934275\ \(0\)\
\-\ sinuses\\:\\ 0\\.006532953664442644\ \(0\)\
\-\ possibly\\:\\ 0\\.006497573800113197\ \(0\)\
\-\ rr\\:\\ 0\\.006480194840583937\ \(0\)\
\-\ neoplasms\\:\\ 0\\.006463016798383231\ \(0\)\
\-\ nerves\\:\\ 0\\.006446035080963286\ \(0\)\
\-\ degeneration\\:\\ 0\\.006446035080963286\ \(0\)\
\-\ obvious\\:\\ 0\\.006412643021747746\ \(0\)\
\-\ order\\:\\ 0\\.006363921145339141\ \(0\)\
\-\ annual\\:\\ 0\\.006363921145339141\ \(0\)\
\-\ cerebellum\\:\\ 0\\.006316746259284788\ \(0\)\
\-\ ear\\:\\ 0\\.006256089506654392\ \(0\)\
\-\ discovered\\:\\ 0\\.006256089506654392\ \(0\)\
\-\ somewhat\\:\\ 0\\.006241304468239581\ \(0\)\
\-\ isointense\\:\\ 0\\.006241304468239581\ \(0\)\
\-\ oriented\\:\\ 0\\.006226665097596176\ \(0\)\
\-\ hr\\:\\ 0\\.006183592977427897\ \(0\)\
\-\ appreciated\\:\\ 0\\.006183592977427897\ \(0\)\
\-\ place\\:\\ 0\\.00616950866248801\ \(0\)\
\-\ women\\:\\ 0\\.00616950866248801\ \(0\)\
\-\ smaller\\:\\ 0\\.006155556596589289\ \(0\)\
\-\ testing\\:\\ 0\\.0061417343192307254\ \(0\)\
\-\ shift\\:\\ 0\\.006022800132494416\ \(0\)\
\-\ orbital\\:\\ 0\\.006022800132494416\ \(0\)\
\-\ volume\\:\\ 0\\.005997615053276327\ \(0\)\
\-\ remainder\\:\\ 0\\.0059851808041373735\ \(0\)\
\-\ without\\:\\ 0\\.005979236749949956\ \(0\)\
\-\ ventricles\\:\\ 0\\.00597284974497735\ \(0\)\
\-\ degree\\:\\ 0\\.005948490443676196\ \(0\)\
\-\ injuries\\:\\ 0\\.00592452405150698\ \(0\)\
\-\ gait\\:\\ 0\\.005912684274910877\ \(0\)\
\-\ 39\\:\\ 0\\.005900938094365389\ \(0\)\
\-\ ischemia\\:\\ 0\\.005900938094365389\ \(0\)\
\-\ t\\:\\ 0\\.005877720682919503\ \(0\)\
\-\ optic\\:\\ 0\\.005877720682919503\ \(0\)\
\-\ vision\\:\\ 0\\.005866246617401063\ \(0\)\
\-\ complaint\\:\\ 0\\.005866246617401063\ \(0\)\
\-\ restricted\\:\\ 0\\.005843560923298852\ \(0\)\
\-\ defects\\:\\ 0\\.005832346650437956\ \(0\)\
\-\ flair\\:\\ 0\\.00582121638040949\ \(0\)\
\-\ incidence\\:\\ 0\\.00582121638040949\ \(0\)\
\-\ deficits\\:\\ 0\\.005810168864083311\ \(0\)\
\-\ basal\\:\\ 0\\.00578831723348941\ \(0\)\
\-\ those\\:\\ 0\\.00577751075603164\ \(0\)\
\-\ margins\\:\\ 0\\.005766782304362268\ \(0\)\
\-\ incidentally\\:\\ 0\\.005756130759817524\ \(0\)\
\-\ well\\:\\ 0\\.005744668508079201\ \(0\)\
\-\ diffusion\\:\\ 0\\.005683634230591028\ \(0\)\
\-\ clinic\\:\\ 0\\.005673560401489425\ \(0\)\
\-\ appearing\\:\\ 0\\.0056437423286056065\ \(0\)\
\-\ \\'s\\:\\ 0\\.005598949831699985\ \(0\)\
\-\ 14\\:\\ 0\\.005595337914884043\ \(0\)\
\-\ mixed\\:\\ 0\\.00557640919901862\ \(0\)\
\-\ may\\:\\ 0\\.0055700694469483615\ \(0\)\
\-\ clinically\\:\\ 0\\.0055670345048235755\ \(0\)\
\-\ large\\:\\ 0\\.005552874983153283\ \(0\)\
\-\ cranial\\:\\ 0\\.005521028226065824\ \(0\)\
\-\ bp\\:\\ 0\\.005511995468151437\ \(0\)\
\-\ complaints\\:\\ 0\\.005511995468151437\ \(0\)\
\-\ absent\\:\\ 0\\.005503017289167838\ \(0\)\
\-\ frequently\\:\\ 0\\.005503017289167838\ \(0\)\
\-\ neurological\\:\\ 0\\.005494093033506305\ \(0\)\
\-\ lateral\\:\\ 0\\.005487869377784696\ \(0\)\
\-\ suspected\\:\\ 0\\.005467637424838389\ \(0\)\
\-\ measures\\:\\ 0\\.005433080423108423\ \(0\)\
\-\ external\\:\\ 0\\.005399308876187835\ \(0\)\
\-\ osseous\\:\\ 0\\.005390984573738102\ \(0\)\
\-\ compared\\:\\ 0\\.005374474580535918\ \(0\)\
\-\ limited\\:\\ 0\\.005358146019502344\ \(0\)\
\-\ general\\:\\ 0\\.005350048538421266\ \(0\)\
\-\ distress\\:\\ 0\\.005350048538421266\ \(0\)\
\-\ defined\\:\\ 0\\.005350048538421266\ \(0\)\
\-\ adenoma\\:\\ 0\\.005302369022000018\ \(0\)\
\-\ done\\:\\ 0\\.005263772459736629\ \(0\)\
\-\ same\\:\\ 0\\.005233601187580989\ \(0\)\
\-\ tissues\\:\\ 0\\.005211368092964774\ \(0\)\
\-\ 12\\:\\ 0\\.00519672872232137\ \(0\)\
\-\ upon\\:\\ 0\\.0051894627709184096\ \(0\)\
\-\ presenting\\:\\ 0\\.005175036598367205\ \(0\)\
\-\ lesion\\:\\ 0\\.005172526674592733\ \(0\)\
\-\ results\\:\\ 0\\.005125620221314482\ \(0\)\
\-\ third\\:\\ 0\\.005091302665898956\ \(0\)\
\-\ temporal\\:\\ 0\\.005084533250541065\ \(0\)\
\-\ measuring\\:\\ 0\\.00507779453558506\ \(0\)\
\-\ solid\\:\\ 0\\.00506440810179254\ \(0\)\
\-\ diagnostic\\:\\ 0\\.005031460319482997\ \(0\)\
\-\ system\\:\\ 0\\.004999227296286475\ \(0\)\
\-\ minimal\\:\\ 0\\.004999227296286475\ \(0\)\
\-\ matter\\:\\ 0\\.004999227296286475\ \(0\)\
\-\ pressure\\:\\ 0\\.004986527354862317\ \(0\)\
\-\ 24\\:\\ 0\\.004936786003901857\ \(0\)\
\-\ midline\\:\\ 0\\.004912526132746687\ \(0\)\
\-\ developed\\:\\ 0\\.0048886559952967526\ \(0\)\
\-\ structures\\:\\ 0\\.0048886559952967526\ \(0\)\
\-\ meningioma\\:\\ 0\\.004882747899636069\ \(0\)\
\-\ 8\\:\\ 0\\.004747574380756832\ \(0\)\
\-\ which\\:\\ 0\\.0047403999620878115\ \(0\)\
\-\ appears\\:\\ 0\\.004726194384542717\ \(0\)\
\-\ clear\\:\\ 0\\.004694690361287735\ \(0\)\
\-\ abnormality\\:\\ 0\\.004684335726345546\ \(0\)\
\-\ diagnosed\\:\\ 0\\.004668937825846962\ \(0\)\
\-\ ap\\:\\ 0\\.004643624026214618\ \(0\)\
\-\ middle\\:\\ 0\\.004643624026214618\ \(0\)\
\-\ intensity\\:\\ 0\\.004589406651380834\ \(0\)\
\-\ required\\:\\ 0\\.004570171637128178\ \(0\)\
\-\ otherwise\\:\\ 0\\.004560646706428447\ \(0\)\
\-\ identified\\:\\ 0\\.004537098129548768\ \(0\)\
\-\ the\\:\\ 0\\.004519293110668302\ \(0\)\
\-\ then\\:\\ 0\\.004518524336436983\ \(0\)\
\-\ complete\\:\\ 0\\.004468612086160556\ \(0\)\
\-\ to\\:\\ 0\\.004442015986776974\ \(0\)\
\-\ sign\\:\\ 0\\.004398880388951071\ \(0\)\
\-\ cerebral\\:\\ 0\\.004398880388951071\ \(0\)\
\-\ benign\\:\\ 0\\.004381947053541161\ \(0\)\
\-\ headache\\:\\ 0\\.0043610481984632955\ \(0\)\
\-\ elevated\\:\\ 0\\.0043080480852289195\ \(0\)\
\-\ air\\:\\ 0\\.004296081168725061\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.0042921135185677375\ \(0\)\
\-\ areas\\:\\ 0\\.00427243264672521\ \(0\)\
\-\ size\\:\\ 0\\.0042568735087351725\ \(0\)\
\-\ unremarkable\\:\\ 0\\.004203664812306182\ \(0\)\
\-\ along\\:\\ 0\\.004196216756104779\ \(0\)\
\-\ central\\:\\ 0\\.00417775833114407\ \(0\)\
\-\ superior\\:\\ 0\\.004054596875266258\ \(0\)\
\-\ injury\\:\\ 0\\.004047858160310253\ \(0\)\
\-\ day\\:\\ 0\\.004031143877196032\ \(0\)\
\-\ t1\\:\\ 0\\.004024510455013735\ \(0\)\
\-\ between\\:\\ 0\\.004024510455013735\ \(0\)\
\-\ resection\\:\\ 0\\.003959755803150399\ \(0\)\
\-\ approximately\\:\\ 0\\.003928406874525383\ \(0\)\
\-\ some\\:\\ 0\\.0038557626357604144\ \(0\)\
\-\ brain\\:\\ 0\\.0038207303466608646\ \(0\)\
\-\ yo\\:\\ 0\\.0038207303466608646\ \(0\)\
\-\ patient\\:\\ 0\\.00381838899368375\ \(0\)\
\-\ there\\:\\ 0\\.003779243852793428\ \(0\)\
\-\ from\\:\\ 0\\.003763553382330497\ \(0\)\
\-\ in\\:\\ 0\\.0037568846669264926\ \(0\)\
\-\ and\\:\\ 0\\.003744615275261602\ \(0\)\
\-\ not\\:\\ 0\\.0036695948640176382\ \(0\)\
\-\ cystic\\:\\ 0\\.003662158554608853\ \(0\)\
\-\ fluid\\:\\ 0\\.0036086762326951755\ \(0\)\
\-\ carcinoma\\:\\ 0\\.0035987038187457153\ \(0\)\
\-\ all\\:\\ 0\\.0035912681863763604\ \(0\)\
\-\ time\\:\\ 0\\.0035863316898058135\ \(0\)\
\-\ 4\\:\\ 0\\.0035378482989287447\ \(0\)\
\-\ presented\\:\\ 0\\.00346115547551621\ \(0\)\
\-\ cm\\:\\ 0\\.0034055811557458927\ \(0\)\
\-\ enhancement\\:\\ 0\\.0034034008411932184\ \(0\)\
\-\ than\\:\\ 0\\.003326967094975147\ \(0\)\
\-\ patients\\:\\ 0\\.003286143535462148\ \(0\)\
\-\ for\\:\\ 0\\.003250110618021018\ \(0\)\
\-\ on\\:\\ 0\\.003226854438478877\ \(0\)\
\-\ more\\:\\ 0\\.003175596299126547\ \(0\)\
\-\ acute\\:\\ 0\\.0031350361502325338\ \(0\)\
\-\ physical\\:\\ 0\\.0031151638478175902\ \(0\)\
\-\ soft\\:\\ 0\\.0030920159940468796\ \(0\)\
\-\ tissue\\:\\ 0\\.003009541141831491\ \(0\)\
\-\ man\\:\\ 0\\.003002870494933134\ \(0\)\
\-\ of\\:\\ 0\\.002942889470380094\ \(0\)\
\-\ most\\:\\ 0\\.002931404371066978\ \(0\)\
\-\ mri\\:\\ 0\\.0029172003787735806\ \(0\)\
\-\ exam\\:\\ 0\\.00278935206530392\ \(0\)\
\-\ had\\:\\ 0\\.002739747131115465\ \(0\)\
\-\ but\\:\\ 0\\.002708028679098867\ \(0\)\
\-\ findings\\:\\ 0\\.0027025808852748283\ \(0\)\
\-\ \\.\\:\\ 0\\.0026901580103486774\ \(0\)\
\-\ right\\:\\ 0\\.002679440443121595\ \(0\)\
\-\ multiple\\:\\ 0\\.0026743031255264025\ \(0\)\
\-\ within\\:\\ 0\\.0024221863423270155\ \(0\)\
\-\ be\\:\\ 0\\.0019580337642554667\ \(0\)\
\-\ with\\:\\ 0\\.0019124010950799216\ \(0\)\
\-\ left\\:\\ 0\\.0014206616185333057\ \(0\)\
\-\ a\\:\\ 0\\.0011786026799958432\ \(0\)\
